Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human Stanniocalcin 2 Antikörper:
anti-Mouse (Murine) Stanniocalcin 2 Antikörper:
anti-Rat (Rattus) Stanniocalcin 2 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Monoclonal Stanniocalcin 2 Primary Antibody für ELISA, WB - ABIN563714
Yokobori, Mimori, Ishii, Iwatsuki, Tanaka, Kamohara, Ieta, Kita, Doki, Kuwano, Mori: Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer. in Annals of surgical oncology 2010
Show all 4 Pubmed References
Recombinant human and fish STC2 proteins were generated and found to be N-glycosylated homodimers. STC2 is a functional homodimeric glycoprotein, and thecal cell-derived STC2 could play a paracrine role during follicular development. (Stanniocalcin-2)
Results show that STC2 promotes head and neck squamous cell carcinoma cell proliferation, tumor growth, and metastasis through the PI3K (zeige PIK3CA Antikörper)/AKT (zeige AKT1 Antikörper)/Snail (zeige SNAI1 Antikörper) pathway.
STC2 promotes colorectal cancer tumorigenesis and epithelial-mesenchymal transition (EMT (zeige ITK Antikörper)) progression through activating ERK (zeige EPHB2 Antikörper)/MEK (zeige MAP2K1 Antikörper) and PI3K (zeige PIK3CA Antikörper)/AKT (zeige AKT1 Antikörper) signaling pathways.
Our results demonstrated the contrasting effects of STC1 (zeige STC1 Antikörper) and STC2-derived peptides on human macrophage foam cell formation associated with ACAT1 (zeige ACAT1 Antikörper) expression and on HASMC migration.
Mus81 (zeige MUS81 Antikörper) knockdown suppresses proliferation and survival of HCC (zeige FAM126A Antikörper) cells likely by downregulating STC2 expression, implicating Mus81 (zeige MUS81 Antikörper) as a therapeutic target for HCC (zeige FAM126A Antikörper).
These findings indicated that STC2 may promote osteoblast differentiation and mineralization by regulating ERK (zeige EPHB2 Antikörper) activation
STC2 is involved in regulating PAPP-A (zeige PAPPA Antikörper) activity during the development of atherosclerosis
Data suggest that stanniocalcin 1 (zeige STC1 Antikörper) and 2 (STC1 (zeige STC1 Antikörper), STC2) participate in inhibition of proteolytic activity of pregnancy-associated plasma protein-A (PAPP-A (zeige PAPPA Antikörper)) during folliculogenesis.
Up-regulation of CDK2 and CDK4 and down-regulation of cell cycle inhibitors p16 and p21 were observed after the delivery of STC2. Furthermore, STC2 transduction activated pAKT and pERK 1/2 signal pathways.
The results showed that the expression of HMGA2 and STC2 was positively correlated. Furthermore, STC2 expression was significantly associated with tumor grade and histotype.
This study utilized ER+ IBC to identify a metagene including ABAT (zeige ABAT Antikörper) and STC2 as predictive biomarkers for endocrine therapy resistance.
results in MTA2 recruitment to the Stc2 promoter, concomitant with agonist-specific epigenetic modifications targeting histone H4 lysine acetylation
Stanniocalcin-2 inhibits proteolytic release of IGF and its ability to cause growth retardation upon transgenic overexpression in mice depends on its proteinase inhibitory function.
The Stc2 promoter contains multiple putative xenobiotic response elements.
These results suggest that the up-regulation of STC2 gene expression resulting from abnormal alpha-klotho (zeige KL Antikörper)-Fgf23 (zeige FGF23 Antikörper) signaling may contribute to limitation of ectopic calcification.
These results define a novel molecular function for STC2 as a negative modulator of Store-Operated Calcium Entry and provide the first direct evidence for the regulation of Ca2 (zeige CA2 Antikörper)+ homeostasis by mammalian STC2.
STC2 is linked to PERK signalling in acinar cells and has a role in limiting damage during pancreatic injury.
induced STC2 expression is an essential feature of survival component of the unfolded-protein response
The murine stanniocalcin 2 gene is a negative regulator of postnatal growth.
This gene encodes a secreted, homodimeric glycoprotein that is expressed in a wide variety of tissues and may have autocrine or paracrine functions. The encoded protein has 10 of its 15 cysteine residues conserved among stanniocalcin family members and is phosphorylated by casein kinase 2 exclusively on its serine residues. Its C-terminus contains a cluster of histidine residues which may interact with metal ions. The protein may play a role in the regulation of renal and intestinal calcium and phosphate transport, cell metabolism, or cellular calcium/phosphate homeostasis. Constitutive overexpression of human stanniocalcin 2 in mice resulted in pre- and postnatal growth restriction, reduced bone and skeletal muscle growth, and organomegaly. Expression of this gene is induced by estrogen and altered in some breast cancers.
, STC-related protein
, stanniocalcin-related protein